Compare Merck & Co., Inc. (MRK) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Merck & Co., Inc. trades at $131.51 (market cap $321.77B), while Direxion Daily TSLA Bull 2X Shares trades at $7.97. The key difference: Merck & Co., Inc. pays a 2.61% dividend while Direxion Daily TSLA Bull 2X Shares pays none, and Merck & Co., Inc. is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| MRK | TSLL | |
|---|---|---|
Market Cap | $321.77B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $131.84 | $23.03 |
52-Week Low | $77.60 | $6.74 |
Enterprise Value | $368.53B | — |
Dividend Yield | 2.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $130.9, up 1.81% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $140.36. Recent earnings beats and a 72.97% gross margin highlight strong profitability, while the acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline. The stock faces headwinds from a high P/E ratio of 104.34 and fluctuating cash flows.
The outlook is positive with robust fundamentals and strategic M&A, but valuation concerns and competitive pressures in pharma pose risks. Upside is likely if earnings growth continues, though investors should monitor debt levels and integration of acquisitions.
TSLL (Direxion Daily TSLA Bull 2X Shares ETF) trades at $8.15, down 0.73% on the day, with technical indicators showing a bearish trend. The ETF, which aims to deliver twice Tesla's daily returns, faces challenges as recent news highlights volatility risks for leveraged Tesla investments. Key support sits at $8 with resistance at $9, while RSI levels suggest mixed momentum signals.
The outlook remains cautious given the bearish technical signals and leveraged structure amplifying Tesla's volatility. Investment opportunities exist for short-term traders betting on Tesla rebounds, but risks include magnified losses during downturns and the structural decay of daily reset leveraged ETFs in volatile markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
